Clinical Trial Update: Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases [Phase 4]

View source ↗

Summary

Updates on a Phase 4 trial evaluating icotinib in combination with whole-brain radiation therapy for patients with non-small cell lung cancer and brain metastas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non-small-cell Lung Cancer | Phase 4 | Status: UNKNOWN